Marinus Pharmaceuticals reported $292K in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 2.41M 277K
Amgen AMGN:US USD 1.75B 159M
Biogen BIIB:US USD 570.9M 101.4M
Eisai 4523:JP JPY 46.74B 1.6B
Esperion Therapeutics ESPR:US USD 4.16M 2.35M
Gilead Sciences GILD:US USD 1.4B 1000K
Intercept Pharmaceuticals ICPT:US USD 28K 396K
Intra Cellular Therapies ITCI:US USD 6.79M 938K
Marinus Pharmaceuticals MRNS:US USD 292K 244K
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Ptc Therapeutics PTCT:US USD 10.89M 3.12M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Sarepta Therapeutics SRPT:US USD 30.8M 9.15M
Supernus Pharmaceuticals SUPN:US USD 22.95M 2.92M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
YTE INCY:US USD 53.76M 4.48M